Abstract
Population receptive field (pRF) mapping based on functional magnetic resonance imaging (fMRI) is an ideal method for obtaining detailed retinotopic information. One particularly promising application of pRF mapping is the estimation and quantification of visual field effects, for example scotomata in patients suffering from macular dysfunction or degeneration (MD) or hemianopic defects in patients with intracranial dysfunction. However, pRF mapping performance is influenced by a number of factors including spatial and temporal resolution, distribution of dural venous sinuses and patient performance. This study addresses the ability of current pRF methodology to assess the size of simulated scotomata in healthy individuals. The data demonstrate that central scotomata down to a radius of 2.35° (4.7° diameter) visual angle can be reliably estimated in single subjects using high spatial resolution protocols and multi-channel receive array coils.
Original language | English |
---|---|
Pages (from-to) | 342-351 |
Number of pages | 10 |
Journal | NeuroImage |
Volume | 169 |
Early online date | 15 Dec 2017 |
DOIs | |
Publication status | Published - 1 Apr 2018 |
Bibliographical note
Funding Information:The authors declare that this work was partially funded by an investigator-initiated and unrestricted research grant from Novartis(CRFB002AAT06T) C. Windischberger acknowledges financial support from the Austrian Ministry of Science, Research and Economy (HSRM project LE103HSK02). G. Holder acknowledges support from NIHR (National Institute for Health Research, UK) and the Foundation Fighting Blindness (USA).
Funding Information:
The authors declare that this work was partially funded by an investigator-initiated and unrestricted research grant from Novartis ( CRFB002AAT06T ) C. Windischberger acknowledges financial support from the Austrian Ministry of Science, Research and Economy (HSRM project LE103HSK02 ). G. Holder acknowledges support from NIHR (National Institute for Health Research, UK) and the Foundation Fighting Blindness (USA).
Publisher Copyright:
© 2017
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
Funding
The authors declare that this work was partially funded by an investigator-initiated and unrestricted research grant from Novartis(CRFB002AAT06T) C. Windischberger acknowledges financial support from the Austrian Ministry of Science, Research and Economy (HSRM project LE103HSK02). G. Holder acknowledges support from NIHR (National Institute for Health Research, UK) and the Foundation Fighting Blindness (USA). The authors declare that this work was partially funded by an investigator-initiated and unrestricted research grant from Novartis ( CRFB002AAT06T ) C. Windischberger acknowledges financial support from the Austrian Ministry of Science, Research and Economy (HSRM project LE103HSK02 ). G. Holder acknowledges support from NIHR (National Institute for Health Research, UK) and the Foundation Fighting Blindness (USA).
Funders | Funder number |
---|---|
Austrian Ministry of Science, Research and Economy | |
HSRM | LE103HSK02 |
National Institute for Health Research, UK) | |
Foundation Fighting Blindness | |
Novartis | CRFB002AAT06T |
Novartis | |
National Institute on Disability and Rehabilitation Research | |
National Institute for Health Research | |
Bundesministerium für Wissenschaft, Forschung und Wirtschaft |